The DOI matches its Crossref record.
White Paper on Continuous Bioprocessing May 20–21 2014 Continuous Manufacturing Symposium
Abstract
There is a growing interest in realizing the benefits of continuous processing in biologics manufacturing, which is reflected by the significant number of industrial and academic researchers who are actively involved in the development of continuous bioprocessing systems. These efforts are further encouraged by guidance expressed in recent US FDA conference presentations. The advantages of continuous manufacturing include sustained operation with consistent product quality, reduced equipment size, high-volumetric productivity, streamlined process flow, low-process cycle times, and reduced capital and operating cost. This technology, however, poses challenges, which need to be addressed before routine implementation is considered. This paper, which is based on the available literature and input from a large number of reviewers, is intended to provide a consensus of the opportunities, technical needs, and strategic directions for continuous bioprocessing. The discussion is supported by several examples illustrating various architectures of continuous bioprocessing systems. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A fully integrated continuous manufacturing provides advantages by reducing the costs, improving the quality while speeding up the product release [24, 26]”
From Current PAT Landscape in the Downstream Processing of Biopharmaceuticals (2025) · cites this paper as [24]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 13
- Anderson, 2001, Practical use of continuous processing in developing and scaling up, Org Proc Res Devt, 5, 613, 10.1021/op0100605 · DOI
- Thomas, 2008, Batch-to-continuous—Coming out of age, Chem Eng, 805, 38
- Laird, 2007, Continuous processes in small-scale manufacture, Org Process Res Dev, 11, 927, 10.1021/op700233e · DOI
- Robinson, 1994, “Characterization of a recombinant antibody produced in the course of a high yield fed-batch process, Biotechnol Bioeng, 44, 727, 10.1002/bit.260440609 · DOI
- Reid, 2010, Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down Study of the effect of harvesting by centrifugation on the post-translational Modification Profile, Biotechnol Bioeng, 107, 85, 10.1002/bit.22790 · DOI
- Pacis, 2011, Effects of cell culture conditions on antibody N-linked glycosylation—What affects high MAnnose 5 glycoform, Biotechnol Bioeng, 108, 2348, 10.1002/bit.23200 · DOI
- Clincke, 2013, Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVEBioreactorTM —Part II: Applications for antibody production and cryopreservation, Biotechnol Prog, 29, 768, 10.1002/btpr.1703 · DOI
- Vogel, 2002, Continuous annular chromatography: General characterization and application for the isolation of recombinant protein drugs, Biotech Bioeng, 80, 559, 10.1002/bit.10411 · DOI
- Napadensky, 2013, Continuous countercurrent tangential chromatography for monoclonal antibody purification, Separation Sci Technol, 48, 1289, 10.1080/01496395.2013.767837 · DOI
- Pollock, 2013, Fed-batch and perfusion culture processes: Operational, economic and environmental feasibility under uncertainty, Biotechnol Bioeng, 110, 206, 10.1002/bit.24608 · DOI · Paper page
- Hammerschmidt, 2014, Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation, Biotechnology J, 9, 766, 10.1002/biot.201300480 · DOI
- Pollock, 2013, Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture, J Chromatogr A, 1284, 17, 10.1016/j.chroma.2013.01.082 · DOI
- Warikoo, 2012, Integrated continuous production of recombinant therapeutic proteins, Biotechnol Bioeng, 109, 3018, 10.1002/bit.24584 · DOI · Paper page
Cited by
Fisher, A. C., Kamga, M.-H., Agarabi, C., Brorson, K., Lee, S. L., & Yoon, S. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.08.008 · Cited by 180
Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing
Jiang, M., Severson, K. A., Love, J. C., Madden, H., Swann, P., Zang, L., & Braatz, R. D. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26383 · Cited by 118
Mahal, H., Branton, H., & Farid, S. S. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27774 · Cited by 71
Thakur, G., Hebbi, V., & Rathore, A. S. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27236 · Cited by 64
Schwarz, H., Zhang, Y., Zhan, C., Malm, M., Field, R., Turner, R., Sellick, C., Varley, P., Rockberg, J., & Chotteau, V. (2020) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.12.017 · Cited by 62
Metadata
- Authors
- Konstantinov, K. B., & Cooney, C. L.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 104
- Issue
- 3
- Pages
- 813-820
- ISSN
- 0022-3549
- Cited by
- 306
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: White Paper on Continuous Bioprocessing May 20–21 2014 Continuous Manufacturing Symposium. https://app.cochat.ai/papers/10.1002/jps.24268
- The paper
- Konstantinov, K. B., & Cooney, C. L. (2015). White Paper on Continuous Bioprocessing May 20–21 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences. https://doi.org/10.1002/jps.24268
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.